23andme glp 1 Are you currently taking a GLP-1? Many people navigate GLP-1 treatments with limited insight into how their bodies might respond. 🤷‍♀️ Published this week, scientists identified two genetic variants in the paid package Why GLP-1 medications work better

Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BG, Hans VH et al (2007) The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene

Crystallographic and molecular-modeling studies of lipase B from Candida antarctica reveal a stereospecificity pocket for secondary alcohols

The GLP-1 plotter and tracking tools from SeekPeptides will continue to evolve alongside these treatments, helping researchers make sense of an increasingly complex landscape

Therapeutic Applications Treatments currently approved for commercial use include Liraglutide (Saxenda, Victoza), Semaglutide (Ozempic, Wegovy), and Exenatide (Byetta, Bydureon)

Like any medication, Semaglutide has the potential for side effects

doi: 10.1212/WNL.0000000000003849 178 UngaroRMehandruSAllenPBPeyrin-BirouletLColombelJ